CAS No. 1069-66-5, Valproic acid (sodium salt)

Valproic acid (sodium salt)

NLT 98%
1069-66-5
DY504938
C8H15NaO2
166.19
Sodium Valproate

Bulk Quote Request

Chemical Name Valproic acid (sodium salt)
CAS Number 1069-66-5
MDL Number MFCD00078604
Molecular Formula C8H15NaO2
Molecular Weight 166.19
Synonyms Sodium Valproate
Introduction of 1069-66-5 :

Valproic acid sodium salt (Sodium Valproate) is an HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. Valproic acid sodium salt activates Notch1 signaling and inhibits proliferation in small cell lung cancer (SCLC) cells. Valproic acid sodium salt is used in the treatment of epilepsy, bipolar disorder and prevention of migraine headaches. IC50 & Target: IC50: 400 μM (HDAC1), 0.5-2 mM (HDAC)[5] HDAC2[6] In Vitro: Valproic acid sodium salt (Sodium Valproate) inhibits the growth dose- and time-dependently with an IC50 of appr 10 and 4 mM at 24 and 72 h, respectively. Valproic acid sodium salt significantly attenuates the activities of total, cytosol and nuclear HDACs. Valproic acid sodium salt increases the form of acetylated histone 3 in HeLa cells. Valproic acid sodium salt (1-3 mM) induces a G1 phase arrest, while 10 mM Valproic acid sodium salt significantly induces a G2/M phase arrest of cell cycle in HeLa cells. In addition, Valproic acid sodium salt increases the percentage of sub-G1 cells in HeLa cells in a dose-dependent manner at 24 h[1].
Valproic acid sodium salt inhibits the mRNA and protein expression of VEGF, VEGFR2 and bFGF. Valproic acid sodium salt inhibits the protein expression of HDAC1, increases histone H3 acetylation, and enhances the accumulation of hyperacetylated histone H3 on VEGF promoters[2].
Valproic acid sodium salt treatment results in increased levels of phosphorylated AMPK/ACC in primary mouse hepatocytes. Phosphorylation of ACC following Valproic acid sodium salt treatment is AMPK-dependent. Valproic acid sodium salt inhibits the deacetylase activity of both mouse liver nuclear extracts and human recombinant HDAC1 while of the metabolites of Valproic acid, only 2-ene-Valproic acid and 4-ene-Valproic acid diminish deacetylase activity[4].
In Vivo: Valproic acid sodium salt (Sodium Valproate; 500 mg/kg, i.p.) inhibits the tumor growth and angiogenesisin the mice transplanted with Kasumi-1 cells. The IR rate in the Valproic acid sodium salt group is 57.25% at the end of the experiment[2].
Valproic acid sodium salt (350 mg/kg, i.p.) demonstrates more social investigation and play fighting than control animals[3].

Purity NLT 98%
Storage at 20ºC 2 years
*The above information is for reference only.

Bulk Quote Request

Change